Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The role of masks, testing and contact tracing in preventing COVID-19 resurgences: a case study from New South Wales, Australia

RM Stuart, Romesh G. Abeysuriya, Cliff C. Kerr, Dina Mistry, Daniel J. Klein, Richard Gray, Margaret Hellard, Nick Scott
doi: https://doi.org/10.1101/2020.10.09.20209429
RM Stuart
1Department of Mathematical Sciences, University of Copenhagen, Copenhagen, Denmark
2Disease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: robyn@math.ku.dk
Romesh G. Abeysuriya
2Disease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cliff C. Kerr
3Institute for Disease Modeling, Global Health Division, Bill & Melinda Gates Foundation, Seattle, USA
4School of Physics, University of Sydney, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dina Mistry
3Institute for Disease Modeling, Global Health Division, Bill & Melinda Gates Foundation, Seattle, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel J. Klein
3Institute for Disease Modeling, Global Health Division, Bill & Melinda Gates Foundation, Seattle, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Gray
5The Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret Hellard
2Disease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia
6School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
7University of Melbourne, Parkville, Victoria, Australia
8Department of Infectious Diseases, The Alfred Hospital and Monash University, Melbourne, Victoria, Australia
9The School of Population and Global Health and the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nick Scott
2Disease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia
6School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives The early stages of the COVID-19 pandemic illustrated that SARS-CoV-2, the virus that causes the disease, has the potential to spread exponentially. Therefore, as long as a substantial proportion of the population remains susceptible to infection, the potential for new epidemic waves persists even in settings with low numbers of active COVID-19 infections, unless sufficient countermeasures are in place. We aim to quantify vulnerability to resurgences in COVID-19 transmission under variations in the levels of testing, tracing, and mask usage.

Setting The Australian state of New South Wales, a setting with prolonged low transmission, high mobility, non-universal mask usage, and a well-functioning test-and-trace system.

Participants None (simulation study)

Results We find that the relative impact of masks is greatest when testing and tracing rates are lower (and vice versa). Scenarios with very high testing rates (90% of people with symptoms, plus 90% of people with a known history of contact with a confirmed case) were estimated to lead to a robustly controlled epidemic, with a median of ∼180 infections in total over October 1 – December 31 under high mask uptake scenarios, or 260–1,200 without masks, depending on the efficacy of community contact tracing. However, across comparable levels of mask uptake and contact tracing, the number of infections over this period were projected to be 2-3 times higher if the testing rate was 80% instead of 90%, 8-12 times higher if the testing rate was 65%, or 30-50 times higher with a 50% testing rate. In reality, NSW diagnosed 254 locally-acquired cases over this period, an outcome that had a low probability in the model (4-7%) under the best-case scenarios of extremely high testing (90%), near-perfect community contact tracing (75-100%), and high mask usage (50-75%), but a far higher probability if any of these were at lower levels.

Conclusions Our work suggests that testing, tracing and masks can all be effective means of controlling transmission. A multifaceted strategy that combines all three, alongside continued hygiene and distancing protocols, is likely to be the most robust means of controlling transmission of SARS-CoV-2.

Strengths and limitations of this study

  • A key methodological strength of this study is the level of detail in the model that we use, which allows us to capture many of the finer details of the extent to which controlling COVID-19 transmission relies on the balance between testing, contact tracing, and mask usage.

  • Another key strength is that our model is stochastic, so we are able to quantify the probability of different epidemiological outcomes under different policy settings.

  • A key limitation is the shortage of publicly-available data on the efficacy of contact tracing programs, including data on how many people were contacted for each confirmed index case of COVID-19.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Australian NHMRC

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Not applicable

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Revised manuscript in response to reviewer comments, and added a comparison between what the model projected and what occurred over October-December 2020.

Data Availability

All code and data analysed during this study are available in https://github.com/optimamodel/covid_nsw

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted February 01, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The role of masks, testing and contact tracing in preventing COVID-19 resurgences: a case study from New South Wales, Australia
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The role of masks, testing and contact tracing in preventing COVID-19 resurgences: a case study from New South Wales, Australia
RM Stuart, Romesh G. Abeysuriya, Cliff C. Kerr, Dina Mistry, Daniel J. Klein, Richard Gray, Margaret Hellard, Nick Scott
medRxiv 2020.10.09.20209429; doi: https://doi.org/10.1101/2020.10.09.20209429
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
The role of masks, testing and contact tracing in preventing COVID-19 resurgences: a case study from New South Wales, Australia
RM Stuart, Romesh G. Abeysuriya, Cliff C. Kerr, Dina Mistry, Daniel J. Klein, Richard Gray, Margaret Hellard, Nick Scott
medRxiv 2020.10.09.20209429; doi: https://doi.org/10.1101/2020.10.09.20209429

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (76)
  • Allergy and Immunology (196)
  • Anesthesia (54)
  • Cardiovascular Medicine (489)
  • Dentistry and Oral Medicine (89)
  • Dermatology (56)
  • Emergency Medicine (168)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (211)
  • Epidemiology (5681)
  • Forensic Medicine (3)
  • Gastroenterology (215)
  • Genetic and Genomic Medicine (866)
  • Geriatric Medicine (88)
  • Health Economics (231)
  • Health Informatics (762)
  • Health Policy (390)
  • Health Systems and Quality Improvement (252)
  • Hematology (105)
  • HIV/AIDS (182)
  • Infectious Diseases (except HIV/AIDS) (6474)
  • Intensive Care and Critical Care Medicine (390)
  • Medical Education (117)
  • Medical Ethics (28)
  • Nephrology (92)
  • Neurology (847)
  • Nursing (44)
  • Nutrition (141)
  • Obstetrics and Gynecology (163)
  • Occupational and Environmental Health (260)
  • Oncology (514)
  • Ophthalmology (163)
  • Orthopedics (44)
  • Otolaryngology (106)
  • Pain Medicine (48)
  • Palliative Medicine (21)
  • Pathology (149)
  • Pediatrics (250)
  • Pharmacology and Therapeutics (146)
  • Primary Care Research (114)
  • Psychiatry and Clinical Psychology (966)
  • Public and Global Health (2228)
  • Radiology and Imaging (377)
  • Rehabilitation Medicine and Physical Therapy (174)
  • Respiratory Medicine (312)
  • Rheumatology (109)
  • Sexual and Reproductive Health (80)
  • Sports Medicine (82)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (34)
  • Urology (42)